Terkko Navigator / American Journal of Psychiatry

An Introduction and Vision

Polygenic Risk Scores in Clinical Schizophrenia Research

Impulse Control Disorders in Parkinson’s Disease

Thinking About Schizophrenia in an Era of Genomic Medicine

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia

Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories

Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis

Multimodal Structural Neuroimaging Markers of Brain Development and ADHD Symptoms

Brain Mechanisms of Attention Orienting Following Frustration: Associations With Irritability and Age in Youths

Comment on Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States

Misuse of Immediate-Release Stimulants: Response to Diller

Controlled Substances in the Polydrug Epidemic: Response to Diller

The Trouble With Burnout: An Update on Burnout-Depression Overlap

Burnout and Depression: Same Phenomenon or Overlapping Constructs? Response to Bianchi et al.

Use of Disulfiram for Treatment of Alcohol Addiction in Patients With Psychotic Illness

EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness

CORRECTION

Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness

Connectome-Based Prediction of Cocaine Abstinence

Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine

The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank

Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder

Adolescents Who Self-Harm and Commit Violent Crime: Testing Early-Life Predictors of Dual Harm in a Longitudinal Cohort Study

Allele-Specific Methylation of SPDEF: A Novel Moderator of Psychosocial Stress and Substance Abuse

The Emergent Course of Bipolar Disorder: Observations Over Two Decades From the Canadian High-Risk Offspring Cohort

Development and Validation of a Dementia Risk Prediction Model in the General Population: An Analysis of Three Longitudinal Studies

Protective Effects of Pregnancy on Risk of Alcohol Use Disorder

Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD

Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts

A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development

CORRECTION

An Introduction and Vision

Polygenic Risk Scores in Clinical Schizophrenia Research

Impulse Control Disorders in Parkinson’s Disease

Thinking About Schizophrenia in an Era of Genomic Medicine

Allele-Specific Methylation of SPDEF: A Novel Moderator of Psychosocial Stress and Substance Abuse

The Emergent Course of Bipolar Disorder: Observations Over Two Decades From the Canadian High-Risk Offspring Cohort

Development and Validation of a Dementia Risk Prediction Model in the General Population: An Analysis of Three Longitudinal Studies

A Farewell

Is There Really Nothing New Under the Sun? Is Low-Dose Ketamine a Fast-Acting Antidepressant Simply Because It Is An Opioid?

Prazosin for the Treatment of Alcohol Use Disorders

Accurate Assessment of Risk of Major Malformations in Infants With First-Trimester Exposure to Quetiapine

2018 in Review

An Unanticipated Outcome of a DNA Ancestry Test

Perspectives on the Management of Vascular Depression

When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips

T.R. Beck (1791–1855)